Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More Detailed PR

More Detailed PR

posted on Aug 15, 2007 05:49AM
I would venture to say at this point a more detailed PR on the K would not benefit us.  If the warrants are being repurchased at a weighted monthly average it would not be in our best interest to pump the price over the next 2 months.  It will only drain more cash from our reserves.  I'm sure Turley isn't looking to give away more money than necessary.  I think the PR for the moment is perfectly acceptable.
Share
New Message
Please login to post a reply